pembrolizumab,docetaxel,erdafitinib,vinflunine
janssen,pierre fabre,merck
['urothelial carcinoma', '#thor', 'urothelial', 'erdafitinib', 'bladder', 'thor trial']
 exciting results from the #thor trial presented at #asco2023 show that #erdafitinib, an #fgfrinhibitor, significantly improves outcomes in advanced urothelial carcinoma compared to chemotherapy. #asco23 #bladdercancer daniel p. petrylak, 
Leader GU @InstitutoRoffo #GU #RCC #prostate #bladder #testis #GUcsm #clinicaltrials #Immunotherapy #PrecisionMedicine #OncoAlert #OncoReporte
Views Mine